Citadel Advisors »

Reneo Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Reneo Pharmaceuticals (RPHM) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Reneo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Reneo Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reneo Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $132k 82k 1.60
2023-09-30 $118k 16k 7.62
2023-06-30 $200k 31k 6.56
2022-06-30 $457k 173k 2.65

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Reneo Pharmaceuticals

NEA Management Company
Tang Capital Management
Carlyle
RiverVest Venture Management
Octagon Capital Advisors
BML Capital Management
Ikarian Capital
Highbridge Capital Management
Vanguard Group
Aisling Capital Management
Caption Management
Two Sigma Investments
Millennium Management
LMR Partners
GSA Capital Partners

View all funds holding Reneo Pharmaceuticals